AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.Right who wrote (1061)	1/29/1998 9:46:00 PM
From: D.Right	Read Replies (4) of 2173

Some good news. It is not first-hand info, but can be confirmed by simply calling the campany (I didn't). Someone told me he heard from someone eles who was at the H&Q conf. as saying that AMLN stated around 75% of all their previous trial IIIs patients were still on pramlintide as of then (two weeks ago). That is 75% for both type I and type II patients, no decrease from last Aug. when the results were released. These patients have been off the trial III from Nov. 1996 to Jun. 1997, so they are on pramlintide for an average close to one year already by now. This is exteremly positive if true. If something doesn't help you much, will you inject it for a year even if it is free? I know I wouldn't. Even better, for half of the 75%, they have been on premlintide for two years now (one year trial plus the close to one year open-lable). This is some news, especially from type II patients. It pretty much takes care of the number two question I listed in post #1058. Hang on, everyone. D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next